6-Ethylchenodeoxycholic acid
Inquiry
| Post Date: | Oct 14,2014 |
| Expiry Date: | Apr 12,2015 |
| Detailed Description: |
Cas No. :459789-99-2
Specs:98% We are the first company in domestic to approach this product at the moment. Sample is available on Mid-Oct, 2014. Good service, your good business partner. Other Drug Names: OCA, Intercept; DSP-1747; FXR agonists, Intercept; INT-747; farnesoid X receptor agonists, Intercept; 6ECDCA; UPF-747; obeticholic acid： OCA, Intercept; DSP-1747; FXR agonists, Intercept; INT-747; farnesoid Xreceptor agonists, Intercept; 6ECDCA; UPF-747; obeticholic acid Innovator: Intercept Pharmaceuticals Inc; Sumitomo Dainippon Pharma Co Ltd Inactive Companies： Universita di Perugia Sep, 2014, highest status: Phase 3 Clinical Active Indication: Liver disease; Primary sclerosing cholangitis; Alcoholic hepatitis; Primary biliary cirrhosis; Diarrhea; Portal hypertension; Non-alcoholic steatohepatitis Inactive Indications:Jaundice;Non alcoholic fatty liver disease Farnesoid X receptor agonist Other Actions: Anti-inflammatory; Bile acid modulator Technologies: Oral formulation; Small molecule therapeutic |
| CAS Registry Number: | 459789-99-2 |
| Synonyms: | ;6-ECDCA;6-Ethylchenodeoxycholic acid;Obeticholic Acid; |
| Molecular Formula: | C26H44O4 |
| Molecular Weight: | 420.6252 |
| Molecular Structure: | 
|
| Company: | SHANGHAI SHARING TECHNOLOGIES CO., LTD. [ China ] |
| Contact: | Zhang |
| Tel: | +86-21-56152668 |
| Fax: | 021-51861772 |
| Email: | sharing@sharingtechcn.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
